Esagian, S.M. Khaki, A.R. Diamantopoulos, L.N. Carril-Ajuria, L. Castellano, D. De Kouchkovsky, I. Park, J.J. Alva, A. Bilen, M.A. Stewart, T.F. McKay, R.R. Santos, V.S. Agarwal, N. Jain, J. Zakharia, Y. Morales-Barrera, R. Devitt, M.E. Nelson, A. Hoimes, C.J. Shreck, E. Gartrell, B.A. Sankin, A. Tripathi, A. Zakopoulou, R. Bamias, A. Rodriguez-Vida, A. Drakaki, A. Liu, S. Kumar, V. Lythgoe, M.P. Pinato, D.J. Murgic, J. Fröbe, A. Joshi, M. Isaacsson Velho, P. Hahn, N. Alonso Buznego, L. Duran, I. Moses, M. Barata, P. Galsky, M.D. Sonpavde, G. Yu, E.Y. Msaouel, P. Koshkin, V.S. Grivas, P., Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes, BJU international (Papier), (128), 196-205, 2021, John Wiley and Sons Inc,